In phase I, grade 4 neutropenia was frequent. In phase II, 10 of 19 evaluable patients showed PSA response and 3 of 10 achieved an objective response. Significant demethylation of GADD45A was observed. This evidence concerns the gene GADD45A and Decreased total neutrophil count.